Theoretically, this potentially selective inhibition might provide a dual benefit in research aimed at reducing cellular senescence with minimal disruption to the cell's natural protective mechanisms against oxidative stress
This study suggests that because the drugs tackle the drivers (plaques and tangles), they should be tested in earlier stages of the disease, years before memory loss actually starts
A compounded GLP-1 is a specialized, FDA-approved medication that can support weight loss, administered via injections
Nichols WC, Pankratz N, Marek DK, Pauciulo MW, Elsaesser VE, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T, Parkinson Study Group-PROGENI Investigators (2009) Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset
In contrast, recommendations where evidence has been appraised and rigorously evaluated, such as those from WHO and IDF, include SUs as the best options for second-line management [12, 43, 92]
